Medicines (MDCO)

35.76 +0.00  +0.00%  May 17, 8:00PM
Add to Watchlists Create an Alert

Medicines R&D Expense Quarterly:

58.20M for Dec. 31, 2012
View Full Chart

Medicines R&D Expense Quarterly Chart

    Medicines Historical R&D Expense Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 58.20M
    Dec. 31, 2012 26.15M
    Sept. 30, 2012 34.54M
    June 30, 2012 32.96M
    March 31, 2012 32.78M
    Dec. 31, 2011 33.30M
    Sept. 30, 2011 26.55M
    June 30, 2011 26.54M
    March 31, 2011 23.79M
    Dec. 31, 2010 31.11M
    Sept. 30, 2010 16.68M
    June 30, 2010 20.58M
    March 31, 2010 16.88M
    Dec. 31, 2009 48.92M
    Sept. 30, 2009 22.46M
    June 30, 2009 21.78M
    March 31, 2009 24.44M
    Dec. 31, 2008 23.20M
    Sept. 30, 2008 44.08M
    June 30, 2008 19.78M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
       
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro

    About R&D Expense

    R&D expenses are a line item from many companies' income statements.

    R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.

    Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.

    An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
    Learn More

    Get data for

    MDCO R&D Expense Quarterly Benchmarks

    Companies
    Warner Chilcott 30.00M
    Acura Pharmaceuticals 2.026M
    Sagent Pharmaceuticals 4.261M

    MDCO R&D Expense Quarterly Rankings

    Overall 97th percentile
    176 of 8008
    Sector 93rd percentile
    45 of 685 in Healthcare
    Industry 89th percentile
    7 of 68 in Drug Manufacturers - Specialty & Generic

    MDCO R&D Expense Quarterly Range, Past 5 Years

    Minimum 16.68M Sep 2010
    Maximum 58.20M Mar 2013
    Average 29.24M